Male factor infertility is the largest cause segment in China's Infertility Market, valued at USD 118.29 million in 2024. Historically overlooked in fertility discussions, male infertility is now gaining recognition as a significant contributor—approximately 50% of infertility cases involve male factors. Rising awareness, improved diagnostic capabilities, and changing social attitudes are driving demand for male-focused fertility services.

The China Infertility Market reflects this shift. Male infertility is now the largest cause segment, ahead of ovulatory disorders, tubal factors, and uterine abnormalities. Diagnostic testing for male infertility—including semen analysis, hormonal testing, and genetic screening—is expanding. Treatment options include medication, surgery (such as varicocele repair), and ART procedures like ICSI that address severe male factor infertility.

Cultural shifts are supporting this trend. Traditionally, infertility was viewed as a women's issue, but this is changing as awareness campaigns and educational initiatives highlight male reproductive health. Government policies supporting family planning and fertility treatment are also contributing. As diagnosis improves and treatment options expand, male factor infertility is expected to remain the largest cause segment in China's Infertility Market, driving growth in diagnostics, treatment, and supportive services.

People Also Ask

• How common is male infertility?
  Approximately 50% of infertility cases involve male factors, making it a significant cause of infertility.

• What causes male infertility?
  Causes include hormonal imbalances, genetic factors, physical issues such as varicocele, and environmental/lifestyle factors.

Tags: #MaleInfertility #ChinaHealthcare #Infertility #ReproductiveHealth #FertilityTreatment #MensHealth